Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
Dysregulated Transcription Therapeutics	6.29M

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
United States	6.29M